Method for optimizing thiopurine efficacy and toxicity using mass spectrometry

Details for Australian Patent Application No. 2005306614 (hide)

Owner Prometheus Laboratories Inc.

Inventors Dervieux, Thierry

Agent Watermark

Pub. Number AU-B-2005306614

PCT Pub. Number WO2006/055527

Priority 60/628,728 16.11.04 US; 11/274,104 14.11.05 US

Filing date 15 November 2005

Wipo publication date 26 May 2006

Acceptance publication date 12 May 2011

International Classifications

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/055527 Priority application(s): WO2006/055527

12 May 2011 Application Accepted

  Published as AU-B-2005306614

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005306618-Peptidomimetic polymers for antifouling surfaces

2005306612-Protein tyrosine phosphatase inhibitors and methods of use thereof